HealthcarePress Releases

Cell Lysis & Disruption Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2030

Share This Article

The cell lysis & disruption market was exceeded US$ 3.7 billion in 2020 and is projected to reach US$ 7.1 billion by 2030, expanding at an annual CAGR of 6.7 percent, according to a 2021 study by Precedence Research, the Canada-based market Insight Company. The report contains 150+ pages with detailed analysis.

The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The dairy products market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Cell lysis is extensively used for immunoassays for the point of care diagnostics, diagnosis for pathogens, determining mRNA transcriptome, and understanding the functions and structure of proteins. The extensive use of cell lysis & disruption technology for diagnosis of cancer is driving the growth of the market. Further, increased adoption of biotechnology in the agriculture and pharmaceutical industries is boosting the cell lysis consumption rapidly. Moreover, the development and growth of the biopharmaceutical industry directly affects the growth of the cell lysis and disruption market as purification and retrieval of biopharma products and medicines requires cell lysis. Hence rising demand from the biopharmaceuticals is propelling the market growth. The growing popularity of personalized medicine, advancements in the metabolomics and proteomics is positively impacting the cell lysis and disruption market.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1292

Market Report Scope

Report Highlights Details
Market Size US$ 7.1 Billion by 2030
Growth Rate CAGR of 6.7% From 2021 to 2030
Base Year 2020
Forecast Period 2021 to 2030
Segments Covered Product, Cell Type, Application, End User, Region

Competition Landscape

In the final section of the research report, Precedence Research provided the global cell lysis & disruption market structure and a detailed competition landscape to provide a dashboard view of key players operating in the cell lysis & disruption market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the cell lysis & disruption market include:

  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Qiagen NV
  • Parr Instrument Company
  • Covaris Inc.
  • Merck KGaA
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Claremont BioSolutions
  • Becton Dickinson & Company

Crucial factors accountable for market growth are:

  • Growing demand from the biopharmaceutical industry
  • Rapid growth of the biopharmaceutical industry
  • Presence of numerous biotechnology companies
  • Increased investments in the research and development by the private players
  • Development of the personalized medications
  • Growing demand for the bioprocess solutions due to the development of biologics
  • Rising adoption of ultrasonic homogenization
  • Growing uses of instrument such as sonicators and homogenizers in cell fractionation

Report Highlights

  • Based on the product, the instrument segment is estimated to be the most opportunistic market owing to the rising uses of instruments like blender, homogenizers, and sonicators. These instruments are very effective in extracting large samples and large volumes of mammalian cells with less oxidation during extraction.
  • By cell type, the mammalian cells were the dominating segment in 2020. Mammalian cells have wide and extensive uses in the production of the key biopharma products like viral vaccines, gene based therapies, and cell-based therapies. The growing incidences of chronic diseases and increased adoption of gene therapies for treatment is exponentially propelling the segment growth.
  • By application, the protein isolation dominated the market in 2020. The increased demand for the efficient protein extracting technologies is propelling the segment growth because of the loss of protein cells through oxidation during the extraction of proteins from the mammalian cells.
  • By end use, the pharma & biotechnology companies registered the highest market share in 2020 due to the increased usage of cell lysis technology for conducting researches on the molecular bilogy.

Market Dynamics

Drivers – The cell lysis & disruption market is primarily driven by the growing demand for the cell disruption technology and rising adoption of mammalian cell in the cell lysis industry. Further the rapid growth of the cell therapies and gene therapies owing to the growing preferences of the people in treatment of various chronic diseases is significantly boosting the market growth.

Restraints – The major retraining factors include high costs of the equipment used in the cell lysis & disruption and lack of skilled professionals. These are the major restraints that may hamper the market growth in the upcoming years. Moreover, the cell-based researches involve high costs and are a key restraint.

Opportunity – The emerging markets such as China, South Korea, India, and Brazil offers lucrative growth opportunities to the market players owing to the rising prevalence of various chronic disease, huge government expenditure in building healthcare infrastructure for facilitating research activities, and increasing penetration of research laboratories funded by the private players.

Challenges – The high costs involved may restrict the new entrants in the market and make the survival of the small players difficult. For surviving in the market, the players need to reduce their operational costs in order to focus on the research activities, which is very difficult for the small players in the market.

Regional Snapshots

North America dominated the global cell lysis & disruption market in 2020 and is expected to retain its dominance during the forecast period. This is attributed to the existence of huge number of research organizations coupled increased investments by the private players for the research and development of various biopharmaceutical products. According to the Pharmaceutical Research and Manufacturers Association, around US$ 80 billion was invested in the research & development of biopharmaceuticals in 2018 in US. Moreover, the US holds around one-third of the global biopharmaceutical market and hence with the growth of the biopharmaceutical industry in US, the cell lysis and disruption market in North America is also anticipated to grow at a rapid pace. Moreover, growing prevalence of chronic disease along with the growing geriatric population and rising adoption of cell therapies is positively boosting the demand for the cell lysis technology in the region.

On the other hand, the Asia Pacific is expected to be the fastest-growing cell lysis and disruption market during the forecast period. The demand for the cell therapy for cancer treatment is gaining rapid traction in the markets such as China, Japan, and South Korea, which is augmenting the market growth. Further, the rising investments in the region for the development of the biologic industry are expected to significantly fuel the market growth during the forecast period.

Market Segmentation

By Product

  • Instruments
  • Reagents

By Cell Type

  • Bacteria Cells
  • Mammalian Cells
  • Plant Cells
  • Yeast/Fungi/Algae

By Application

  • Cell Organelle Isolation
  • Protein Isolation
  • Downstream Processing
  • Nucleic Acid Isolation

By End Use

  • Hospitals and Diagnostic Laboratories
  • Cell Banks
  • Academic and Research Institutions
  • Pharma & Biotechnology Companies

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and

Questionnaire based research etc.

  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Most Asked Questions –

  • What was the market size value of the cell lysis & disruption in 2020?
  • What is the expected market size by 2030?
  • What is the cell lysis & disruption market growth?
  • What are the key factors that positively influence market growth?
  • Who are the prominent players in the cell lysis & disruption market?

Why should you invest in this report?

If you are aiming to enter the global cell lysis & disruption market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for cell lysis & disruption are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1292

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Cell Lysis & Disruption Market, By Product

7.1. Cell Lysis & Disruption Market, by Product Type, 2021-2030

7.1.1. Instruments

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Reagents

7.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Cell Lysis & Disruption Market, By Application

8.1. Cell Lysis & Disruption Market, by Application, 2021-2030

8.1.1. Cell Organelle Isolation

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Protein Isolation

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Downstream Processing

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Nucleic Acid Isolation

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Cell Lysis & Disruption Market, By Cell Type 

9.1. Cell Lysis & Disruption Market, by Cell Type, 2021-2030

9.1.1. Bacteria Cells

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Mammalian Cells

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Plant Cells

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Yeast/Fungi/Algae

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Cell Lysis & Disruption Market, By End Use Type 

10.1. Cell Lysis & Disruption Market, by End Use Type, 2021-2030

10.1.1. End Use

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Cell Banks

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Academic and Research Institutions

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Pharma & Biotechnology Companies

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Cell Lysis & Disruption Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.1.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.1.5. U.S.

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.1.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.1.6. Rest of North America

11.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.1.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.5. UK

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.6. Germany

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.7. France

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.8. Rest of Europe

11.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.5. India

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.6. China

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.7. Japan

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.8. Rest of APAC

11.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.5. GCC

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.6. North Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.7. South Africa

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.8. Rest of MEA

11.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.5.5. Brazil

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.5.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.5.6. Rest of LATAM

11.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.5.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Danaher Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Qiagen NV

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Parr Instrument Company

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Covaris Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Merck KGaA

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bio-Rad Laboratories

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. F. Hoffmann-La Roche Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Claremont BioSolutions

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Becton Dickinson & Company

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Follow us on LinkedIn | Twitter | Facebook

Show More

Market Stats News

Market Stats News is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services, we aim at connecting an organization’s goal with lucrative prospects globally.

Related Articles

Back to top button